These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30281805)

  • 1. Impact of route of administration on genotoxic oestrogens concentrations using oral vs transdermal oestradiol in girls with Turner syndrome.
    Mauras N; Torres-Santiago L; Santen R; Mericq V; Ross J; Colon-Otero G; Damaso L; Hossain J; Wang Q; Mesaros C; Blair IA
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):155-161. PubMed ID: 30281805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.
    Bannink EM; van Sassen C; van Buuren S; de Jong FH; Lequin M; Mulder PG; de Muinck Keizer-Schrama SM
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):265-73. PubMed ID: 19200215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of oral versus transdermal 17β-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome.
    Torres-Santiago L; Mericq V; Taboada M; Unanue N; Klein KO; Singh R; Hossain J; Santen RJ; Ross JL; Mauras N
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2716-24. PubMed ID: 23678038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There a Difference between Ultrasonographic (US) Uterine Changes of Oral Versus Transdermal (TD) 17β Estradiol (17β E2) in Girls with Turner Syndrome (TS)? Own Experience and Literature Review.
    Kraus J; Unanue N; Espinoza A; Iniguez G; Torres-Santiago L; Singh R; Mauras N; Mericq V
    Pediatr Endocrinol Rev; 2018 Sep; 16(1):178-185. PubMed ID: 30371036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndrome.
    Taboada M; Santen R; Lima J; Hossain J; Singh R; Klein KO; Mauras N
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3502-10. PubMed ID: 21880799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens and Their Genotoxic Metabolites Are Increased in Obese Prepubertal Girls.
    Mauras N; Santen RJ; Colón-Otero G; Hossain J; Wang Q; Mesaros C; Blair IA
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2322-8. PubMed ID: 25856214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
    Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome.
    Mauras N; Shulman D; Hsiang HY; Balagopal P; Welch S
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4154-60. PubMed ID: 17711924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
    Aedo AR; Sundén M; Landgren BM; Diczfalusy E
    Maturitas; 1989 Jun; 11(2):159-68. PubMed ID: 2547139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
    Sonnet E; Lacut K; Roudaut N; Mottier D; Kerlan V; Oger E
    Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
    Aedo AR; Landgren BM; Diczfalusy E
    Maturitas; 1990 Nov; 12(4):333-43. PubMed ID: 2124648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.
    Helle SI; Omsjø IH; Hughes SC; Botta L; Hüls G; Holly JM; Lønning PE
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):727-32. PubMed ID: 9039339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sitting, physical activity, and serum oestrogen metabolism in postmenopausal women: the Women's Health Initiative Observational Study.
    Oh H; Arem H; Matthews CE; Wentzensen N; Reding KW; Brinton LA; Anderson GL; Coburn SB; Cauley JA; Chen C; Goodman D; Pfeiffer RM; Falk RT; Xu X; Trabert B
    Br J Cancer; 2017 Sep; 117(7):1070-1078. PubMed ID: 28817836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualised vs fixed dose of oral 17β-oestradiol for induction of puberty in girls with Turner syndrome: an open-randomised parallel trial.
    Labarta JI; Moreno ML; López-Siguero JP; Luzuriaga C; Rica I; Sánchez-del Pozo J; Gracia-Bouthelier R;
    Eur J Endocrinol; 2012 Oct; 167(4):523-9. PubMed ID: 22807477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of oestrogens: impact of the route of administration.
    Ho KK; O'Sullivan AJ; Wolthers T; Leung KC
    Ann Endocrinol (Paris); 2003 Apr; 64(2):170-7. PubMed ID: 12773957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A physiological mode of puberty induction in hypogonadal girls by low dose transdermal 17 beta-oestradiol.
    Illig R; DeCampo C; Lang-Muritano MR; Prader A; Torresani T; Werder EA; Willi U; Schenkel L
    Eur J Pediatr; 1990 Dec; 150(2):86-91. PubMed ID: 2126236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of serum oestrogen levels after percutaneous and oral administration of oestradiol-17 beta.
    Lyrenäs S; Carlström K; Bäckström T; von Schoultz B
    Br J Obstet Gynaecol; 1981 Feb; 88(2):181-7. PubMed ID: 7459307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oestrogen effects on calcitriol levels in post-menopausal women: a comparison of oral versus transdermal administration.
    Dick IM; Prince RL; Kelly JJ; Ho KK
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):219-24. PubMed ID: 7554318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial and vaginal response to three different oestrogen preparations administered by the transdermal and oral routes.
    Johannisson E; Landgren BM; Diczfalusy E
    Maturitas; 1988 Oct; 10(3):181-92. PubMed ID: 3185292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.